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Tuberculosis is a worldwide health problem with 2 billion people infected with Mycobacterium
tuberculosis (Mtb, the bacteria causing TB). The hallmark of infection is the emergence of organized
structures of immune cells forming primarily in the lung in response to infection. Granulomas
physically contain and immunologically restrain bacteria that cannot be cleared. We have developed
several models that spatially characterize the dynamics of the host–mycobacterial interaction, and
identified mechanisms that control granuloma formation and development. In particular, we published
several agent-based models (ABMs) of granuloma formation in TB that include many subtypes of T cell
populations, macrophages as well as key cytokine and chemokine effector molecules. These ABM
studies emphasize the important role of T-cell related mechanisms in infection progression, such as
magnitude and timing of T cell recruitment, and macrophage activation. In these models, the priming
and recruitment of T cells from the lung draining lymph node (LN) was captured phenomenologically.
In addition to these ABM studies, we have also developed several multi-organ models using ODEs to
examine trafficking of cells between, for example, the lung and LN. While we can predict temporal
dynamic behaviors, those models are not coupled to the spatial aspects of granuloma. To this end, we
have developed a multi-organ model that is hybrid: an ABM for the lung compartment and a non-linear
system of ODE representing the lymph node compartment. This hybrid multi-organ approach to study
TB granuloma formation in the lung and immune priming in the LN allows us to dissect protective
mechanisms that cannot be achieved using the single compartment or multi-compartment ODE
system. The main finding of this work is that trafficking of important cells known as antigen presenting
cells from the lung to the lymph node is a key control mechanism for protective immunity: the entire
spectrum of infection outcomes can be regulated by key immune cell migration rates. Our hybrid multi-
organ implementation suggests that effector CD4þ T cells can rescue the system from a persistent
infection and lead to clearance once a granuloma is fully formed. This could be effective as an
immunotherapy strategy for latently infected individuals.
& 2011 Elsevier Ltd. All rights reserved.1. Introduction
1.1. Epidemiology of TB
Tuberculosis (TB) is a deadly infectious disease caused by
Mycobacterium tuberculosis (Mtb) in humans (Kumar and Robbins,
2007): inhalation of a single droplet containing just a few bacteria
(as few as 2–5) can lead to infection (Behr et al., 1999; Nicas et al.,
2005). This is remarkable, especially when considering that most
infectious diseases require an initial dose of more than 1000
bacteria, and some as high as 109 bacteria (Zak and Sande, 1999).ll rights reserved.
: þ1 734 647 7723.
).If the immune response does not clear initial infection (clearance
scenario), Mtb is able to persist in a (clinically) asymptomatic
latent state in the majority of infected hosts (called latent TB
infection or LTBI). There is, however, a small chance that an
infected individual will initially progress to active TB (Kumar and
Robbins, 2007; Selwyn et al., 1989) (characterized as uncontrolled
bacterial growth and/or disseminating infection), which, if
untreated, can result in death rates of more than 50% of infected
hosts (Onyebujoh et al., 2006). Approximately 2 million deaths
due to TB occurred in 2008, including 500,000 people with HIV-1/
AIDS (2009). Moreover, each person with active TB can infect on
average 10–15 people every year (2009). Clinical epidemiological
data have revealed that the risk of progression to active disease
(3–10%) of infected individuals, defined as a PPD (purified protein
derivative) skin test conversion, is much higher for the first few
S. Marino et al. / Journal of Theoretical Biology 280 (2011) 50–62 51years waning over time (Vynnycky and Fine, 2000). Of particular
importance is that factors resulting in these different infection
outcomes in humans are not well-characterized. Of great concern
is that TB persists as a latent infection in one-third of the world
population (2 billion people), providing a reservoir of potential
disease and contagion: individuals with latent infection have a
10% lifetime chance of reactivation, a number that increases in the
presence of HIV-1/AIDS.
Treatment of both latent and active TB is difficult and requires
long courses of multiple antibiotics. Antibiotic resistance is a
growing problem, leading to untreatable cases such as (exten-
sively) multi-drug-resistant tuberculosis (XDR-TB), which occurs
when resistance to second-line drugs develops on top of multi-
drug-resistant tuberculosis (MDR-TB).
1.2. Host immunity to TB
TB manifests in different forms, but the most common in adults
is pulmonary TB. This work focuses on TB infection in the lung,
while in other work we consider TB meningitis (in preparation).
Upon introduction into lung alveoli environment, Mtb is taken up
by antigen presenting cells (APCs) such as macrophages (Mfs) and
dendritic cells (DCs). TB bacteria have evolved strategies to evade
many of the typical protective host immune mechanisms, espe-
cially in macrophages (such as neutralizing reactive nitrogen
intermediates or preventing phagosome/lysosome fusion) (Rohde
et al., 2007). DCs are less permissive for Mtb replication and change
their phenotype upon internalization of the pathogen (Giacomini
et al., 2001): they start expressing co-stimulatory and adhesion
molecules, and migrate through the lymphatics to lung draining
lymph nodes. Dissemination of bacteria to the draining lymph
node occurs following aerosol infection and the lymph node itself
is the first site of expression of effector function for T cells
(Chackerian et al., 2002). In some cases, further spread occurs
through the bloodstream to other tissues and organs where
secondary TB lesions can develop (kidneys, brain, and bone
(Herrmann and Lagrange, 2005; Kumar and Robbins, 2007)).
Priming (and activation) of specific immune cell types (lym-
phocytes like CD4þ and CD8þ T cells) in the lymph node is key
to the generation of protective adaptive immunity and host
resistance to Mtb infection (Mogues et al., 2001; Orme, 1987).
Priming is performed by APCs in the T cell zone of a lymph node.
The slow or delayed induction of expression of effector functions
of these primed T cells seen in Mtb infection has been shown to be
detrimental to the ultimate success of the response (Chackerian
et al., 2002). This could be due to mechanisms occurring between
Mtb and the host; factors such as inhibiting either cell migratory
activity, modulating antigen presenting cell (APC) function (Chang
et al., 2005) and danger signals (Matzinger, 2002), or by its
extremely slow proliferation rate compared with other bacteria
(Mtb divides every 16–24 h) (Cox, 2004).
Although most exposed individuals do not become infected,
exposure to Mtb results in the development of a strong Th1 host
response (Flynn and Chan, 2001). This is characterized by a host
cellular immune response in the lung, recognizing mycobacterial
antigens that leads to the production of type I cytokines and
activating infected macrophages that kill or at least contain the
bacterial infection (Cooper et al., 1993; Flynn and Chan, 2001;
Flynn et al., 1993).
Tuberculosis is classified as one of the granulomatous inflam-
matory conditions. In fact, the hallmark of Mtb infection is the
emergence of self-organizing structures of immune cells forming
primarily in the lung in response to bacterial invasion. The
purpose of the granuloma is to physically contain and immuno-
logically restrain bacteria that cannot be cleared. Infection trig-
gers inflammation in the pulmonary alveoli environment wherecytokine and chemokine signals (Flynn and Chan, 2001) are
released activating cells and recruiting more immune cells to
aid in granuloma formation. Macrophages, T and B cells and
fibroblasts are among the cells that cluster together, with T cells
surrounding a core of infected macrophages. T cells secrete
cytokines such as interferon gamma (IFN-g), which activates
macrophages to kill their intracellular bacterial load (Kaufmann,
2002). Cytotoxic T cells can also directly kill infected cells, by
secreting perforin and granulysin (Houben et al., 2006). Impor-
tantly, bacteria are not always eliminated within the granuloma,
but can become dormant, a metabolic state often associated with
latent TB infection (Kumar and Robbins, 2007). Another feature of
the granuloma in humans is the development of areas of cell
death, called caseum or necrosis, in the center of granulomas
(Grosset, 2003). Due to anoxic conditions killing of trapped
bacteria and bacteria replication are both inhibited in these
regions. There are various types of human TB granulomas,
including caseous (cheese-like) necrotic, non-necrotizing, fibrotic,
calcified, and suppurative (neutrophilic necrosis). The factors that
lead to different types of granulomas are not known, but each
type may have different immune and microbial microenviron-
ments (Barry et al., 2009). The most common granuloma is the
caseous granuloma, where necrotic cell debris in the center is
surrounded by a rim of large macrophages and a thin zone of
T cells.
1.3. Mathematical and computer models to aid understanding of TB
To spatially characterize mechanisms that control the complex
dynamics and emerging behavior in the lung during TB granu-
loma formation and development and to describe the interplay
between bacteria and host, we published the first agent-based
model (ABM) of granuloma formation in TB in 2004 (Segovia-
Juarez et al., 2004). Based on our parallel studies with equation
based models of TB dynamics (Fallahi-Sichani et al., 2010; Marino
and Kirschner, 2004; Marino et al., 2011, 2004, 2007b; Sud et al.,
2006), we recently developed next generation granuloma agent-
based models (Fallahi-Sichani et al., 2011; Ray et al., 2009) that
include additional T cell populations (e.g., effector CD8þ T cells
and regulatory T cells), as well as key cytokine and chemokine
effector molecules (e.g., tumor necrosis factor-TNF and three
different chemokines, see (Lin et al., 2010)). In the last study
(Fallahi-Sichani et al., 2011), the ABM has been updated to
capture the immune response to Mtb over three biological scales:
molecular, cellular and tissue. This multi-scale computational
modeling platform revealed a critical role for TNF receptor
dynamics in TB granuloma formation. These ABM studies
(Fallahi-Sichani et al., 2011; Ray et al., 2009; Segovia-Juarez
et al., 2004) emphasize the important role of T-cell related
mechanisms in infection progression, such as magnitude and
timing of T cell recruitment, T cell movement and macrophage
activation. However, the current ABM formulation lacks any
mechanism to capture T cell priming, differentiation and recruit-
ment of immune cells to the lung as these events occur in the lung
draining lymph node. Thus, studying these processes in more
mechanistic detail is warranted to obtain a deeper understanding
of their role in infection dynamics.
In other work (Linderman et al., 2010; Marino and Kirschner,
2004; Marino et al., 2004), we have developed a 2-compartmental
ODE model capturing the dynamics of immune cells in the lung
and a single draining LN. This multi-organ model was able to
identify trafficking as an important factor for the outcome of
infection in the lung: delays in either DC migration to the draining
lymph node or T cell trafficking to the site of infection can alter
the outcome of Mtb infection, defining progression to primary
disease or latent infection and reactivated tuberculosis. That
Fig. 1. Schematic of the hybrid model (granuloma ABM linked to a Lymph Node
ODE). The left-hand side of the figure shows some basic steps of the ABM
algorithm in the lung compartment. After cell movement is completed on the
grid, the LN-ODE module (right-hand side of the figure) retrieves information from
the grid (i.e., the sum of infected and chronically infected macrophages) to
initialize the APC equation in the LN-ODE system. Antigen presentation, T cell
priming, proliferation and differentiation are computed for a time span of 10 min.
Effector T cell fluxes (continuous) from the LN to the lung are generated and
passed to a recruitment function that updates a T cell Queue (discrete) and a
Source Table at each iteration (see text for details). The T cell Queue lists randomly
all the effector T cells ready to be input onto the grid. The Source Table lists all the
vascular sources that are enabled on the grid (per T cell phenotype). At any
iteration, we empty the T cell Queue if enough sources are available. Otherwise,
the remaining effector T cells will be placed onto the grid in the next iteration.
Effector cells in the queue have a lifespan of 3 days.
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spatial aspects. Thus, although we know trafficking of cells
between lung and LN is important during TB, we cannot identify
mechanisms that will lend more insight into these dynamics that
can then aid in predicting strategies for treatments and vaccines
for TB.
The work in this paper combines our modeling efforts of TB in
both the lung and lymph node. Herein we have developed for the
first time to our knowledge, a multi-organ model that is hybrid:
an ABM for the lung compartment and a non-linear system of
ODE representing the lymph node compartment. The computa-
tional aspects of linking the two compartments will be described,
along with the details of how to perform sensitivity and uncer-
tainty analysis of a hybrid multi-organ model.
The main finding of this work is that APC trafficking to the
lymph node is a key control mechanism for protective immunity:
the entire spectrum of infection outcomes can be achieved by
regulating APC migration only. More APCs enhance a protective
T cell response in the lung, where both CD4þ and CD8þ effector
functions can successfully stop bacterial invasion and clear infec-
tion before a granuloma is fully established. Our spatial multi-
organ implementation suggests that only effector CD4þ T cells
can rescue the system once a granuloma is fully formed: the
peculiar granuloma structure walls off CTL killing (extracellular
bacteria are in the center of the granuloma and they are very
difficult to reach by CTL cells) and only macrophage activation
(dependent on effector CD4þ T cells) can be effective as an
immunotherapy strategy for latently infected individuals. This
hybrid multi-organ approach to study TB granuloma formation in
the lung and immune priming in the LN allows us to dissect
protective mechanisms that cannot be achieved using the single
compartment or multi-compartment ODE only system.2. Methods
2.1. Multi-organ model implementation
We review some general specifications of the computational
modeling platform used herein. The readers can find all the details
in the published manuscripts for the individual model systems
(Fallahi-Sichani et al., 2011; Ray et al., 2009), as well as in the
diagrams shown in Supplementary Material. We develop our hybrid
model in a computational framework. First, we describe the ABM of
the lung granuloma, and then the ODE system for the LN. Then we
describe how we link them together. Finally, we refine our meth-
odology for performing uncertainty and sensitivity analysis and
apply it here.
2.2. ABM of granuloma formation-lung compartment
The ABM of the lung granuloma is defined by four concepts:
environment, agents within the environment, rules for agent-
agent and agent-environment interactions, and timescales of
these interactions. The virtual granuloma environment captures
a 2 mm2 mm section of lung tissue (i.e., parenchyma, where
the granuloma typically forms) as a 100100 two-dimensional
(2D) grid with micro-compartments scaled approximately to the
size of a macrophage (20 mm in diameter (Krombach et al., 1997)).
Use of the 2D grid speeds computation considerably and other
work has shown that the 2D model approximated well the 3D
model results (Forrest et al., 2006). In addition, the 2D model
serves the purpose here well in creating the hybrid system.
A quick summary of the rules follows.
Cells are represented as discrete agents on the grid: they move
and respond to their environment based on rules reflectingknown biological activities. Effector molecules such as chemo-
kines (e.g., CCL2, CCL5, and CXCL9) and the cytokine TNF are
modeled by partial differential equations. Since Mtb is a non-
motile bacterium, we assume that bacteria do not diffuse and we
capture their proliferation according to a logistic growth function
within a single micro-compartment with a discretized ordinary
differential equation.
We defined each subtype of T cell based on their immunolo-
gical functions: interferon-g (IFN-g)-producing T cells (Tg), cyto-
toxic T cells or CTL (TC) and regulatory T cells (Treg). As the lungs
are highly vascularized, 50 vascular sources are randomly placed
on the grid and serve as entries for resting macrophages and
effector T cells, representing 0.5% of the grid (personal commu-
nication by JoAnne Flynn). The initial number of macrophages
represents 1% coverage of the grid (Condos et al., 1998; Law
et al., 1996; Schwander et al., 1998). Resting macrophages
populate the grid in the absence of infection, then post-infection,
they can become infected, chronically infected and activated,
depending on intracellular and extracellular bacterial load, and
cell–cell interaction with IFN-g (via Tg) and/or TNF. Each cell type
can die of age or apoptosis (TNF-dependent, Tg-cells dependent)
or killing. Infected macrophages can be killed by CTLs and
chronically infected macrophages can burst. Each mechanism
can affect the bacterial count. A flowchart of the algorithm of
the simulation is also shown in Fig. 1.
2.3. ODE priming model: lymph node compartment
We use the lymph-node compartment portion of our two-
compartmental ODE model (Marino et al., 2010b) to capture
mechanisms of APC and T cell trafficking, as well T cell priming
and differentiation. For the purpose of this study, we simplify the
LN-ODE model, and do not directly account for bacterial and
cytokine dynamics. The LN-ODE system captures the dynamics of
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to the LN to present to T cells, as well as several subpopulations of
T cells (naı¨ve, precursor and effector CD4þ and CD8þ T cells). A
system of 13 equations total shown below is numerically solved
by an Euler discretization scheme for a 10 min time span (fixed
time step of 6 s).
During any infection, but in particular TB, it is the arrival of
antigen presenting cells-APCs (DCs, macrophages, etc.) at the
draining tissue LN that kick starts the development of adaptive
immunity. To capture this in the model, we define the sum of
infected (MI) and chronically infected macrophages (MCI) in the
granuloma lung compartment at time t as a proxy for the number
of APCs migrating from the site of infection to the lymph node at
any iteration (10 min loop). After an APC successfully finds and
phagocytoses mycobacteria, it migrates out of the lung compart-
ment through lymphatics (ultimately reaching the closest drain-
ing lymph node). Because an APC encounters several possible
delays during this migration, we have defined a parameter that
scales this representation (scalingAPC): it is set to 1 for the
containment scenario (no scaling) but we also can vary it to
simulate vaccination and immunotherapy strategies (see Section
3.7). The equation for APC dynamics is a simple linear decay
kinetics (with half-life given by the parameter mAPC):
dAPC=dt¼mAPCAPC ð1Þ
with initial condition at time t (i.e., APC(t)) seeded by scalingAPC[-
MI(t)þMCI(t)] from the lung compartment. Naı¨ve CD4þ T cells are
described in Eq. (2) with a constant source term (sN4), recruitment
by an APC-dependent recruitment term (k13 term), natural death,Table 1
List of initial conditions and parameter names, descriptions, values, and the ranges u
sensitivity analysis. Rates are per day.
Name Description
mAPC Death rate for antigen presenting cell (APC)
mN4 Death rate for Naı¨ve CD4þ
N4 (0) Initial (uninfected) Naı¨ve CD4þ T cell population
sN4 [¼mN4N4 (0)] Constant source of N4 (LN)
k13 Naı¨ve CD4þ T cells maximum APC-dependent recruitment ra
hs13 MDC half-sat Naı¨ve CD4þ T cells recruitment rate (LN)
k14 Rate (likelihood) of Naı¨ve CD4þ T cell priming when encoun
k15 Precursor Th1 proliferation rate (LN)
r2 Precursor Th1 carrying capacity (LN)
k20a Maximum Th1 differentiation rate, dependent of IL-12 and A
hs20a MDC half-sat on IL-12 and APC dependent Th1 differentiation
x1 Precursor Th1 cells migration rate out of the LN into the bloo
x1a Th1 cells migration rate out of the LN into the blood
mN8 Death rate for Naı¨ve CD8þ
N8 (0) Initial (uninfected) Naı¨ve CD8þ T cell population
sN8 [¼mN8*N8 (0)] Constant source of N8 (LN)
k16 Naı¨ve CD8þ T cells maximum MDC-dependent recruitment r
hs16 MDC half-sat Naı¨ve CD8þ T cells recruitment rate (LN)
k17 Maximum rate (likelihood) of Naı¨ve CD8þ T cell priming wh
hs17 Th1 half-sat rate for Naı¨ve CD8þ T cell priming when encou
k18 Precursor T8/CTL proliferation rate (LN)
r3 Precursor T8/CTL carrying capacity (LN)
k24a Maximum T8/CTL differentiation rate, dependent of IL-12 and
hs24a MDC half-sat on IL-12 and APC dependent T8/CTL differentia
x2 Precursor T8/CTL cells migration rate out of the LN into the b
x2a T8 cells migration rate out of the LN into the blood
x2b CTL cells migration rate out of the LN into the blood
wT80 Weight factor between precursor Th1 and Th1 in Naı¨ve CD8
U Scaling factor between LN and Lung compartments (proxy fo
ScalingAPC Scaling factor between Lung and LN compartments (proxy fo
m Fraction of overlap between T8 (IFN producing CD8þ T’s) an
GR-ABM module
tNFkb TNF thresholds for Nfkb activation of Macsand differentiation to precursor Th1 that depends on APCs (k14
term). Eq. (3) models precursor Th1 cell dynamics. It accounts for
the differentiation of naı¨ve CD4þ T cells, proliferation of Th1 cells
(logistic growth with rate constant k15), differentiation, and migra-
tion into the blood (x1 term). Eq. (4) describes Th1 cell dynamics,
incorporating differentiation via APCs (k20a term) and migration to
the blood (x1a term). Eq. (5) models naı¨ve CD8þ T cell dynamics,
and is similar to the naı¨ve CD4þ cell Eq. (2). There is a source term
(sN8), and mechanisms for recruitment by APCs (k16 term), natural
death, and differentiation to T80 cells (k17 term). The k17 term
captures the role of licensed DCs in priming CD8þ T cells. Licensing
is achieved by initial successful CD4þ T cell priming: that is why
CD8þ T cell priming is only possible if either precursor or fully
effector Th1 cells are present. Eq. (6) describes primed CD8þ T cell
dynamics, with mechanisms for CD8þ T cell proliferation (k18
term), differentiation and migration into the blood (x2 term),
similarly to Eq. (3). Eqs. (7) and (8) describe IFN-g-producing T8
cell and CTL dynamics in the lymph node. Both equations capture
differentiation induced by ACPs (k24a term) and migration to the
blood (x2a and x2b terms). Parameter m allows for an overlap
between IFN-g-producing CD8þ T cell and CTLs. Eqs. (9)–(13)
represent the fluxes of precursor and effector CD4þ and CD8þ
T cells arriving at the site of infection. These fluxes are used to
initialize the new T cell recruitment function within the lung
compartment. The scaling factor U accounts for the possibility of
multiple LN locations for T cell priming surrounding the lung and
eventually multiple sources for effector T cell influx on the grid. We
set it to 2 for the baseline scenario. Parameter and initial condition
values for the LN model are shown in Table 1.sed to initialize the LN compartment ODE model, as well as for uncertainty and
Baseline (containment) LHS ranges
3E1 [2E1,4E1]
2.5 [1E4,1E1]
3E5
7.5E5
te (LN) 1E1 [1E3,1E4]
1E3 [1,1E4]
tering an APC (LN) 1E2 [1E6,1]
5 [1E3,1E4]
1E7 [1E5,1E8]
PC (LN) 1E1 [1E6,1E1]
(LN) 1E3 [1,1E4]
d 1E1 [1E2,1E3]
1E1 [1E2,1E3]
2.5 [1E4,1E1]
2.4E5
6E5
ate (LN) 1E1 [1E3,1E4]
1E3 [1,1E3]
en encountering an APC (LN) 1E2 [1E6,1]
ntering an APC (LN) 1E1 [1,1E2]
5 [1E3,1E4]
1E7 [1E5,1E8]
APC (LN) 5E1 [1E6,1E1]
tion (LN) 1E3 [1,1E3]
lood 1E1 [1E2,1E3]
1E1 [1E2,1E3]
1E1 [1E2,1E3]
differentiation 0.5 [1E2,1]
r multiple LN sources) 2 [1E1,1E1]
r delays in DC trafficking) 1 [1E2,2]
d CTL phenotypes 0.75 [1E1,1]
0.05 [1E2, 1E1]
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their initial values. Containment and disseminating infection
scenarios are described in Section 3:
dN4
dt
¼ sN4þk13N4
APC
APCþhs13
 
mN4N4k14N4 APC ð2Þ
dT^
LN
1
dt
¼ k14N4APCþk15T^
LN
1 1
T^
LN
1
d2
 !
k20aT^
LN
1
APC
APCþhs20a
 
x1T^
LN
1
ð3Þ
dTLN1
dt
¼ k20aT^
LN
1
APC
APCþhs20a
 
x1aTLN1 ð4Þ
dN8
dt
¼ sN8þk16N8
APC
APCþhs16
 
mN8N8k17N8 APC
TLN1 þwTLN80 T^
LN
1
h i
TLN1 þwTLN80 T^
LN
1
h i
þhs17
0
B@
1
CA
ð5Þ
dTLN80
dt
¼ k17N8APC
TLN1 þwTLN80 T^
LN
1
h i
TLN1 þwTLN80 T^
LN
1
h i
þhs17
0
B@
1
CA
þk18TLN80 1
TLN80
r3
 
x2TLN80 k24aTLN80
APC
APCþhs24a
  
ð6Þ
dTLN8
dt
¼m k24aTLN80
APC
APCþhs24a
  
x2aTLN8 ð7Þ
dTLNC
dt
¼m k24aTLN80
APC
APCþhs24a
  
x2bTLNC ð8Þ
dT^1
dt
¼ Urc5x1T^
LN
1 ð9Þ
dT1
dt
¼ Urc5ax1aTLN1 ð10Þ
dT80
dt
¼ Ux2TLN80 ð11Þ
dT8
dt
¼ Ux2aTLN8 ð12Þ
dTC
dt
¼ Ux2bTLNC ð13Þ
2.4. Linking the two models
Effector T cell generation and recruitment are the main
novelties of this new multi-organ ABM implementation. In the
previous versions of the ABM, T cells were recruited to the lung
granuloma through vascular sources at the site of infection (lung)
as already fully differentiated effector T cells in some local
chemokine-gradient dependent fashion. The 50 vascular sources
were sequentially scanned every 10 min and for each source a
T cell type was randomly selected from a uniform probability
density function, with 54%, 36%, and 10% probabilities of choosing
a Tg, TC, or Treg, respectively. These effector T cells were always
available. After the T cell type was chosen, threshold conditions
for recruitment were checked. These thresholds are calculated by
weighted linear combination of TNF and chemokine concentra-
tions at the source (see Ray et al. (2009), and Supplementary Text
in Fallahi-Sichani et al. (2011)). This is based on TNF-dependent
and independent recruitment of T cells via effector molecules
(Ray et al., 2009). If satisfied, a T cell was input onto the grid and
the next source was scanned. T cell recruitment was enabled onlyafter day 20 post-infection. This reflected the ‘delay’ in mounting
adaptive immunity.
Our new implementation uses the LN compartment to gen-
erate fluxes of effector T cells to be input onto the lung ABM grid
(see Fig. 1). These fluxes are a function of the magnitude and
timing of the infection in the lung compartment. The result is a
hybrid multi-compartment mathematical/computational model,
where a discrete/stochastic module is represented by the granu-
loma/lung ABM and the continuous/deterministic module is
captured by a lymph node ODE model. Information is exchanged
between the two compartments at every time step.
2.5. APC trafficking: from the lung to the LN
A full iteration of the ABM is represented by a 10 min time
span. For the purpose of describing the linking of the two
compartments, we label the initial and final times ti and tiþ10
(i¼0,1,2,y,N), respectively. By construction, tiþ10¼tiþ1. The
algorithm computes chemokines and TNF secretion, diffusion
and degradation first, cell movement and then cell recruitment
(macrophage first, then T cells). Cell recruitment function relies
on the numerical solution of the LN-ODE, seeded by inputs from
the lung compartment (see Fig. 1). Initial conditions at the
beginning of the simulation (time t0, onset of infection) for the
LN compartment are all zeros except for naı¨ve T cells (see Table 1
for naı¨ve CD4þ and CD8þ T cell initial conditions). The LN-ODE is
then solved for a 10 min time span (t0þ10) and all the solutions
at time t0þ10 are saved. Then, the fluxes generated by Eqs. (10),
(12), and (13) are passed to a recruitment function which inputs
effector T cells on the ABM grid (see the next section, T cell
recruitment: from the LN to the lung).
The algorithm continues by calculating cell–cell interactions
and state transitions, and then starts the new iteration t1. The sum
of infected and chronically infected macrophages (multiplied by
scalingAPC) is updated starting at time t1 (after the first 10 min of
simulation) and it will be used as initial condition for Eq. (1) for
all the subsequent iterations.
To preserve the continuity of the ODE system, the initial
conditions for the LN compartment at time ti (i40) are retrieved
from the solutions of the LN-ODE saved in the previous time step
ti1þ10. We define DAPC the difference between the sum of
infected and chronically infected macrophages between contig-
uous iterations (tiþ1 and ti): if DAPC40, then the initial condition
for Eq. (1) is updated by adding DAPC to the previous solution
(e.g., APC(tiþ1)¼APC(tiþ10)þDAPC). It is left unchanged other-
wise (as for the rest of the variables of the ODE system). Since the
increments in infected macrophages are discrete (by integers), the
changes in the lung compartment are reflected in the LN-ODE as
pulses of APCs over 10 min intervals. Fig. S1 in the Supplementary
Material shows a numerical solution of the APC Eq. (1) based on
the time course of [MI(t)þMCI(t)] in the grid from a containment
scenario. The time course of APC is usually lower than the
combined infected macrophage trajectories: APC dynamics mirror
[MI(t)þMCI(t)] time courses with a natural delay induced by the
differential Eq. (1) form and by the parameter scalingAPC.
2.6. T cell recruitment: from the LN to the lung
The sum of the fluxes of Eqs. (10) and (12) is used to generate
Interferon g-producing cells (Tg), while the flux of Eq. (13)
describes cytotoxic T cells (TC) dynamics. Regulatory T cells (Treg)
are calculated as 10% of Tg cells.
Given APC inputs, the LN-ODE generates continuous fluxes of
effector T cells that need to be converted into integers before
entering the lung compartment (T cell agents are discrete). We
define a DTcell for each T cell subset and check if DTcell41
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fulfilled we add the correspondent T cell subtype (more than one if
the integers crossed are more than one) to a queue (T cell queue).
During macrophage recruitment, we generate a table (Source table)
of enabled vascular sources. To enable a vascular source for T cell
recruitment, threshold conditions are checked for each source, and
if satisfied, the corresponding source is added to a list (one list per
T cell subtype), sorted by the highest gradient.
Then, a random T cell is chosen from the T cell queue and if the
Source table is not empty for the selected T cell phenotype, the
source on top of the list is selected (highest gradient/threshold
recruitment condition) and the T cell is placed onto the grid and
the T cell queue updated. If the T cell cannot be input onto the grid
(microcompartment is occupied or no source enabled for that
specific phenotype), a separate queue of stand-by cells is gener-
ated (T cell Queue off). This queue (if not empty) has a priority in
the next round of recruitment. T cell recruitment ends when the
Source Table is empty or when both queues are empty. T cells in
the T cell Queue off have a lifespan of 3 days: death cells are
deleted and the queue updated.2.7. Model implementation
This section gives a brief top-level overview of the developed
software; for a more detailed description see (El-Kebir, 2010). For
efficiency reasons, we preferred to do the memory management
manually as our computations involved the creation and deletion
of many objects representing various agents. That is why we used
Cþþ rather than a managed language such as Java (Oracle, 2010)
or any of the .NET languages (Microsoft, 2010). In order for our
software to be cross-platform among Linux, Windows and MacOS
X, we made use of the Qt framework (Nokia, 2010). Qt is a
framework for developing cross-platform applications with a
graphical user interface (GUI). The various visualization techni-
ques including color mapping, isolines, height plots and agent
visualization have been implemented using OpenGL (Khronos,
2010). Through the GUI, the user is able to zoom in on a specific
part of the grid, inspect the contents of a particular micro-
compartment and also view simulation-wide attributes and
statistics in real-time. All of this proceeds without any observable
delays while the simulation is running. The software also allows
the user to save and load model states and alter parameters,
enabling the user to perform depletion experiments regarding a
particular cytokine or chemokine.
Initially we implemented the two-compartmental model as
two separate modules: the lung ABM in pure Cþþ, and the lymph
node ODE model as a Matlab function which takes as input a
vector of initial conditions and returns the same vector with
updated values. Using the Matlab compiler (Mathworks, 2010),
we generated an executable that we called every time step of the
ABM. It turned out, however, that with this approach there was a
significant computational time slowdown mainly due to the
penalty incurred by initializing the Matlab Compiler Runtime
(MCR) every time the executable is called. In addition, it often
occurred that the MCR would crash and output an error dialog
box effectively blocking progress of the entire application. For
these reasons, we chose to re-implement the lymph node com-
partment internally. We did this by employing a forward Euler
integration strategy for solving the ODEs, and verified that our
solving method gave the same results as the method used by
Matlab. Using the Valgrind profiler (Developers, 2010), we could
see that the bottleneck in the computation was, similarly to the
lung ABM model, the diffusion of cytokines and chemokines
rather than in the LN ODE compartment.2.8. Parameter estimation and model validation
Mechanisms of the host–pathogen system are captured by
rates and rate constants of the mathematical model representa-
tion, and these must be estimated from many different experi-
mental sources or by mathematical means in order to perform
simulations. Values for most model parameters of the models are
estimated from published experimental data obtained from the
murine model, and where possible from the non-human primate
model. Mtb experiments are favored over other mycobacterial
species. There is an intrinsic biological and experimental varia-
bility in rates measured from in vivo or in vitro studies. Further,
some interactions in the Mtb-host system are not currently
measurable, particularly at the level of the lung granuloma. This
complicates accurate estimation of model parameters (baseline
values are unknown) as well as model validation.
We conduct model validation in three steps. First we perform
negative control simulations and establish steady state dynamics
with no infection: cells levels are set to known baseline homeo-
static values in both compartments. Then, as a second step, the TB
models must replicate qualitatively typical TB infection outcomes,
such as latency and dissemination. Total bacterial load is usually
used as the best informative marker of TB disease in the ODE
models, where bacterial levels can distinguish between different
scenarios: latent infection (steady state, low stable bacterial
levels), dissemination (unchecked bacterial growth) and clearance
(no Mtb present at the site of infection). In the ABM framework,
we coupled bacterial load with spatial information on disease
progression, such as granuloma size.
As a last validation step, the model should qualitatively
recapitulate experimental data available in the literature from
gene knockouts and neutralization studies. These can be simu-
lated with a mathematical/computational model as virtual dele-
tion and depletion experiments, respectively. Virtual deletions
remove an element from the system at day zero while virtual
depletions mimic experimental conditions where an element can
be depleted or neutralized via antibody treatment at any time
during the infection. Virtual deletion and depletion experiments
can be performed for all of the relevant cells and cytokines in the
model where the experimental results are known.
Since our goal is to inform the human condition for TB
granuloma formation and T cell priming, we rely on non-human
primates (NHPs) data, which are similar to humans in almost all
aspects (Chackerian et al., 2002; Herrmann and Lagrange, 2005).
However, comprehensive and accurate in vivo data collection in
NHPs still remains very difficult and expensive due to technical
limitations and to the slow-progression of TB in this animal
model. This makes quantitative model validation particularly
hard, especially for cell counts by different phenotype during
infection.
2.9. Model calibration
Given a certain set of parameter values (see Table 1), clear-
ance, containment, and disseminating infection can be replicated
by the model. These baseline parameter sets are chosen after
extensive exploration of the parameter space through uncertainty
analysis (see Section 2.10). We have simulated a significant
number of different types of granuloma that could identify a
spectrum within each outcome (via different parameters and
stochasticity). Model robustness is always tested for each infec-
tion scenario (replicating many times the simulation with a fixed
parameter set and different seeds for the stochastic components):
this ensures that any particular outcome of infection is the result
of some biological mechanism in place rather than a random
effect. We focused on varying the LN-ODE module, allowing very
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studies for the ABM lung compartment. Model calibration for
containment has been performed in a semi-quantitative fashion:
LN-ODE model parameters have been varied and we chose the
sets that returned a typical containment scenario in the lung
compartment, with stable and low total bacterial load, mostly
intracellular and stable granuloma size. Clearance and dissemina-
tion outcomes are chosen similarly, checking for either bacterial
clearance or uncontrolled growth. The results of the sensitivity
analysis also guided our search for mechanisms (parameters) to
target in order to achieve these outcomes.
2.10. Uncertainty and sensitivity analysis: determining key factors
that control infection outcomes
We quantify the importance of each host mechanism involved
directly and indirectly in the infection dynamics using statistical
techniques known as uncertainty and sensitivity analyses. We
recently published a review on uncertainty and sensitivity (US)
analyses techniques, with the focus on systems biology applica-
tions (Marino et al., 2008). There we showed how multidimen-
sional parameter spaces can be globally sampled in a
computationally efficient manner by Latin hypercube sampling
(LHS) algorithms. Correlations between model output and para-
meter values can then be determined using partial rank correla-
tion coefficients (PRCC). Time dependent correlations can also be
identified. When combined, these uncertainty and sensitivity
analysis tools (Blower and Dowlatabadi, 1994; Greenland, 2001;
Helton and Davis, 2002; Sanchez and Blower, 1997) guide our
understanding as to how and what extent variability in parameter
values affects infection outcomes. We have used this approach in
our previous equation-based studies (i.e., ordinary, partial and
delay differential equation systems), as well as agent-based
model settings (Gammack et al., 2004; Ganguli et al., 2005;
Marino et al., 2007a; Ray et al., 2009; Segovia-Juarez et al., 2004).
Given the multicompartment nature of our system, detailed
uncertainty and sensitivity (US) analyses was applied to our
model to explore dynamics within the same compartment
(intra-compartmental/intra-scale) or between different compart-
ments or scales (inter-compartmental/inter-scale). Examples of
multiscale/compartment sensitivity analyses can also be found in
our recent work (Chang et al., 2005, 2008; Kirschner et al., 2007).
Here, we vary 28 parameters total: all the parameters in the LN
compartment (27) and 1 in the lung compartment (see Table 1 for
the parameters varied and the ranges used). Our previous ABM
studies highlight a key role for TNF in TB infection dynamics, in
particular TNF thresholds for Nfkb activation of Macs (tNFkb).
Experimental data also suggest how TNF plays an important role
in proper granuloma formation and control. This new implemen-
tation should confirm that finding and we chose to include at
least 1 parameter (e.g., the most important, tNFkb), in the uncer-
tainty and sensitivity analysis. In addition, our focus in this work
is on results occurring in the lung compartment and how varia-
tions in the LN-compartment affect granuloma formation and
function in the lung. We looked at 5 time points during infection
progression: 7, 21, 50, 100, and 200 days.
2.11. Scaling initial conditions of the multi-organ model
In 2-D, the environment of our model represents one complete
slice of a lung parenchyma of a NHP, the tissue where granulomas
form. Each microcompartment of the ABM grid is 20 mm3 and the
total volume represented by the ABM is 2 mm2 mm20 mm¼
0.08 mm3. There is large variation in granuloma sizes, weights
and volumes. Assuming from data on humans and NHPs that a
granuloma is approximately shaped like a sphere, we can projecta volume of 4.2 mm3 for a lesion of 2 mm in diameter: the 3D grid
would be 100 times larger in volume (a cube of 2 mm2 mm
2 mm). Thus we would need to scale up the values we derive to
compare with data. Data on cell trafficking from the site of
infection (lung) to the LN, as well as fluxes of effector T cells
reaching the granuloma in the lung, migrating from the LN, are
not available. Since we are seeding the LN ODE with real-time
output from the 2D ABM, the LN-ODE captures the dynamics of
1/100 of a whole NHP LN. We then set the initial conditions for
naı¨ve CD4þ and CD8þ T cells in the LN-ODE module to
approximately 1/100 of the known data for uninfected LN in
human and NHP (Biancotto et al., 2007; Haase, 1999; Hogue et al.,
2008). Based on our murine data (see (Riggs et al., 2008)), we use
a 6 to 5 CD4/CD8 ratio (although some other data suggest higher
ratios of 2:1, see (Latif et al., 2001)): initial conditions for naı¨ve
CD4þ T’s are set to 3e5 and for naı¨ve CD8þ T cells are set to 20%
less (i.e., 2.4e5). The model can accommodate any ratio.3. Results
3.1. Outcomes of the hybrid, multi-organ model: containment and
disseminated infection
We simulated the hybrid model for 200 days post-infection,
with an initial inoculum of 1 infected macrophage (with 1 intra-
cellular bacterium) in the lung model and 1 extracellular bacter-
ium into a neighboring compartment (the model gives similar
results for other initial conditions). Our focus is on results
occurring in the lung compartment and how variations in the
LN-compartment affect granuloma formation and function in the
lung. Fig. 2 shows typical containment and dissemination snap-
shots of the granulomas at day 200 for 2 different parameter sets
(see Table 1). We compare our hybrid model (ABM–ODE) time
courses of bacteria and T cells to the previous version without the
LN-ODE compartment. Fig. 2 also shows the corresponding TNF
gradient for each snapshot during infection. In addition, TNF and
IFNg virtual deletion experiments confirm known experimental
data: both result in dissemination and uncontrolled growth
scenarios (although IFNg deletion has a faster progression, data
not shown).
3.2. Scaling cell number predictions in the granuloma to NHP data
Latent and active TB are clearly different both in physiology
and pathology. However, there is a large variability in the data
due to an observed wide spectrum governing infection progres-
sion (Capuano et al., 2003; Lin et al., 2009). Moreover, reliable CFU
and cell count (e.g., macrophages and T cells) data from NHP and
human granulomas are difficult to collect (Lin et al., 2009). Here
we use the model as a predictive tool for CFU and cell numbers in
human/NHP TB granulomas during containment and active infec-
tion. Since bacterial load and cell numbers depend on the size of a
granuloma, we need to scale our results from 2D to 3D. To do this,
we measure the diameter of the granuloma emerging at the end
of our model simulation and use it as our radius for the 3D axis.
Table 2 shows the volume of the 2D disk as a function of lesion
diameter (e.g., area of the circle multiplied by the 20 mm thick-
ness of a single micro-compartment) and the volume of a sphere
with the same diameter. The fourth column illustrates the
percentage of volume in the sphere occupied by the 2D disk
and the Projection factor column shows the scaling needed to get a
reasonable approximation of the cell and bacterial counts at the
end of the 200 days simulation in a 3D granuloma with a
specific diameter. We assume that 2D densities are preserved in
the sphere. Therefore, if in a containment scenario at 200 days
Fig. 2. Time courses and snapshots of infection progression during containment and dissemination outcomes as predicted by our ABM. We compare outputs of the original
version of the ABM (without the LN-ODE compartment, Panels A–D and I–L) to the current implementation (ABM–ODE—hybrid multi-compartmental model, Panels E–H
and M–P). A vertical axis (see the *) on the top panels shows the corresponding time of the snapshot in the lower panels. For each snapshot, the corresponding TNF gradient
is also shown (TNF gradient could be use as a proxy for granuloma size). Panels A,B, E, F, I, J, M, and N represent containment. Panels C, D, G, H, K, L, O, and P represent
dissemination.
Table 2
Projection factors to scale the 2D granuloma predictions (cell and bacterial numbers) to a 3D spherical granuloma of equivalent diameter. List of diameter sizes and
corresponding 2D and 3D volumes (assuming a microcompartment volume of 0.08 mm3). The percentage volume occupied by the 2D volume in the 3D sphere is obtained
dividing the 3D by the 2D volume. The projection factor column lists the scaling needed to project cell and bacterial numbers into a 3D spherical granuloma. A complete
table with granuloma sizes from 0.1 to 2 mm in diameter is available in the Supplementary Material (Table S1).
Diameter granuloma (mm) Volume 2D (mm3) Volume 3D (mm3) Percentage of volume occupied by the 2D disk Projection factor
Containment
0.3 0.001413717 0.014137 10 10
0.4 0.002513274 0.03351 7.5 13.33333
0.5 0.003926991 0.06545 6 16.66667
0.6 0.005654867 0.113097 5 20
Dissemination
0.7 0.007696902 0.179594 4.285714 23.33333
0.8 0.010053096 0.268083 3.75 26.66667
0.9 0.01272345 0.381704 3.333333 30
1 0.015707963 0.523599 3 33.33333
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diameter, a rough estimate of the number of Tg cells will be 5000
(i.e., 15033.33). No NHP or human data are available on cellcounts for effector T cells and macrophage subpopulations (acti-
vated and infected) per single granuloma. Some estimates are
available per gram of tissue, while others show T cell data broadly
Table 3
Bacterial and cell number predictions for a NHP or human TB granuloma in typical infection scenarios. The predictions are based on granuloma diameter at day 200 post-
infection. The scaling factors are shown in Table 2.
T cells
Tg TC Treg
Containment 800–1700 600–1300 100–220
Dissemination/active TB 5.4–7.7e3 5–7.1e3 4.8–7e3
Macrophages
Resting Infected Chronically infected Activated
Containment 1.5–3.1e4 120–240 90–180 700–1400
Dissemination/active TB 2.3–3.3e4 2–2.8e3 1.3–1.9e3 5.3–7.7e3
Bacteria
Intracellular Extracellular Total
Containment 1800–3700 300–600 2000–4500
Dissemination/active TB 3–4.2e5 1.5–2.2e5 1.8–2.7e5
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subtypes or specificity (Lin et al., 2009). Using the parameter
values outlined in Table 1, the lesions we obtain for a contain-
ment scenario are very small, between 0.3 and 0.6 mm diameter.
Lesions for active infection and uncontrolled growth are usually
larger, between 0.7 and 1 mm in diameter. For reasonable
bacterial and cell number predictions we then apply the scaling
factors shown in Table 2, depending on the emergent lesion
diameter at day 200. Table 3 shows some prediction ranges for
bacterial and cell numbers in typical infection scenarios. Bacterial
load predictions are in line with data measured by our collabora-
tors on CFU counts per gram of granuloma tissue (see Table 7 in
Marino et al., 2004). According to some recently published data
from Flynn’s group for CD4þ and CD8þ T cell counts in the LN
(see Table 5 in Lin et al., 2009), our LN-ODE predictions are within
the same order of magnitude (given a scaling factor of 1e2, that
accounts for the initial 1/100 scaling of the LN-ODE volume). The
values we predict for CD4þ and CD8þ T cells are very similar and
they are not significantly different between infection outcomes
(i.e., 1.65–2.5e7 for both phenotypes in both scenarios). Our
data are taken at 200 days post-infection, while the data from (Lin
et al., 2009) are averaged over the time of necropsy, which is
different for each monkey (varies between 150 and 400 days).3.3. Investigating immune mechanisms driving infection outcomes,
before and after a granuloma is established
In keeping with our goal of ascertaining how a more mechan-
istic LN compartment affects the dynamics within the lung
granuloma, we performed uncertainty and sensitivity analysis as
described in Methods and in Marino et al. (2008). Results guided
our search for mechanisms occurring in the LN compartment that
can drive the lung system to clearance or active infection starting
from initial infection or from a containment scenario. This helps
us explore what factors control both the formation and the
maintenance of a granuloma. The outputs that we correlate to
parameter variations are total bacterial load, macrophage num-
bers (infected, chronically infected, and activated), effector T cells
on the ABM grid (Tg, CTL, and Tregs) and granuloma size as in Ray
et al. (2009). Bacterial load and infected macrophages, as well as
Tg and Tregs, share the same set of significant PRCCs. Table S2 in
the Supplementary Material shows our detailed LHS-PRCC results.
Below we discuss the most significant findings.3.4. Early impact of T cell priming and proliferation on disease
progression
Proliferation rate of precursor effector CD4þ T cells (k15), and
the maximum Th1 differentiation rate dependent on APCs (k20a)
both have a strongly negative correlation on bacterial load during
early infection (o3 weeks post-infection, see Table S2). Increased
precursor effector CD4þ T cell proliferation and differentiation
rates (k15 and k20a) result in lower bacterial loads at the onset of
infection. Not surprisingly, increasing APC efficiency in priming
naı¨ve CD4þ T’s (k14), as well precursor effector T cell proliferation
(k15) and differentiation (k20a) in the LN has a positive impact on
the levels of fully effector T cells in the lung. This finding is
important, implying that they are having the biggest impact early
at the onset of infection and not after the granuloma has been
established.
3.5. Lymph node shut-down: better chance for clearance?
There are inconclusive data for T cell proliferation at the site of
infection. We input onto the granuloma grid only fully activated
effector T cells: precursor T cells migrating out of the LN are not
accounted for and no differentiation mechanism is captured in
the granuloma. This explains why rates of precursor T cells
migration from the LN to the blood (on the way to the lung, x1
and x2), are consistently significantly correlated to most of the
outcome variables we tracked (see Table S2). We can relate these
rates to a concept known as ‘lymph node shut-down’, a transient,
proportional accumulation of all T cell subsets in a lymph node
draining a site of inflammation (Cahill et al., 1976; Hall and
Morris, 1965; MartIn-Fontecha et al., 2003): higher T cell LN
emigration rates (larger x1 and x2 rates) translate into decreased
lymph node shut-down, and vice versa. LN shut-down likely
facilitates an efficient T cell priming and successful effector T cell
differentiation. Recent findings showed a direct role for migrating
APCs in T cell accumulation in the LN (MartIn-Fontecha et al.,
2003): it is not clear if this accumulation is a common feature of
any viral or bacterial infection. The positive correlation of x1 and
x2 to bacterial load can be explained by a faster migration out of
the LN translating into less chances for full T cell differentiation in
that compartment, therefore less effector T cells are available for
the lung, less Tg cells and less CTL killing in the granuloma
(confirmed by the negative correlation of x1 and x2 to T cell
counts). We tested the impact of increased x1 and x2: protective
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activation is observed (i.e., containment is achieved). On the other
hand, decreasing values for x1 and x2 has a major impact on
infection progression and may contribute to bacterial clearance.
This is only successful early during infection before the granu-
loma is established: infection (see Table S2, Early column) cannot
be cleared by decreasing x1 and x2 once the granuloma has been
established. Another trafficking parameter, the scaling factor U, is
consistently negatively correlated to bacterial burden and gran-
uloma size. U is a proxy for multiple LN sources of precursor and
effector T cells: increasing Ucan partially account for additional
T cell differentiation mechanisms once precursor T cells migrate
out of the LN (see Supplementary Text S1 for more details on
sensitivity analysis results for the scaling factor U).3.6. TNF-dependent macrophage activation: a necessary protective
mechanism
The TNF threshold for NFkb activation of macrophages (tNFkb)
has a consistently strong positive correlation to granuloma size,
late during infection (4100 days). If we increase this threshold,
higher TNF concentrations are required for macrophage activa-
tion, therefore less activated macrophages are generated and less
bacterial killing is observed. More cytokines and TNF are then
secreted due to increased bacterial load and more effector T cellsFig. 3. Enhancing APCs trafficking as a vaccination strategy. Shown are time courses o
effector T cells (Panels D–F) for a vaccination strategy that manipulates APC trafficking
x-axis represents days post-infection and the y-axis the number of cells or number of(Tg, CTL, and Tregs) are recruited to the lung. The next section will
address if single parameter changes in the LN compartment can
protect the host and have a significant impact on granuloma
formation and maintenance.3.7. Vaccination and cell-based immunotherapy strategies
Stimulating the immune response leading to immunological
memory, via use of an infectious agent, is known as immuniza-
tion. Vaccinations involve the administration of one or more
immunogens (molecules or antigenic material that stimulate the
immune response): if they are live bacteria, they are less virulent
than the pathogen itself and only serve the purpose to produce
immunity to a disease and prevent (or ameliorate) the effects of
infection by future exposure to pathogens.
Immunotherapy is related to immunization and vaccination in
the sense that refers to the treatment of disease by inducing,
enhancing (activation immunotherapy), or suppressing (suppres-
sion immunotherapy) an immune response. The active agents of
immunotherapy are called immunomodulators: they are usually
cytokines, but recent effort has been devoted to cell-based immu-
notherapy, where APCs and T cells are stimulated ex-vivo and
transferred into a patient to generate the appropriate immune
response. Based on our uncertainty and sensitivity analysis results
(Table 1), we predict key mechanisms in driving granulomaf infected macrophages (Panel A), APCs (Panel B), bacterial counts (Panel C) and
. We show low and high APC trafficking scenarios, compared to containment. The
bacteria.
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manipulating some of these mechanisms on infection progression,
suggesting potential vaccination and immunotherapy strategies.
For example, since scalingAPC is one of the parameter consis-
tently negatively correlated to bacterial load, infected macro-
phages and granuloma size, we choose to target APC trafficking to
the LN as a possible vaccination strategy. We vary the parameter
scalingAPC in the range [0.01,2] (baseline for containment it is set
to 1) and the impact on infection outcome is significant. For low
values of scalingAPC the system progresses to active infection and
dissemination, while clearance can be obtained with values close
to 2. Fig. 3 compares time courses of MIþMCI, APC, effector T cells
and bacterial load in low and high APC trafficking scenarios
(containment is also shown for comparison). For high DC traffick-
ing (scalingAPC¼1.75) a higher number (comparing to contain-
ment) of APCs reaches the LN at the onset of infection: although
the difference is not dramatic, a few more APCs in the LN early
during infection have a significant impact on the infection
progression (first month, Fig. 3B). A spike in effector T cells by
day 40 (Fig. 3E) results in a fast declining number of infected and
chronically infected macrophages (Fig. 3A) and in bacterial
clearance (Fig. 3C). This highlights the key role of APCs in
regulating a protective immune response to Mtb. The number of
effector T cells is 20 times lower in the low trafficking scenario
comparing to containment (Fig. 3F), and they reach the granu-
loma site when it is already too late to control infection (Fig. 3D).
Similar clearance scenarios can be obtained by increasing APC
efficiency in priming naı¨ve CD4þ T’s (k14) or naı¨ve CD8þ T’s
(k17). We use values of 1e1 and 1 for k14 and k17. Coupling the
effect (e.g., both k14 and k17 are set to high values, such as 1) has a
similar result (clearance). Interestingly, lowering the efficiency of
T cell priming does not compromise a protective immune
response: a stable granuloma always forms (but with a slightly
higher bacterial load) and containment is always achieved by day
200 (data not shown). This result suggests how different levels of
bacterial load are possible within the spectrum of latency, as
shown in Lin et al. (2009).
We then tested how to disturb a stable granuloma to manipulate
a containment scenario to try to shift the system to clear infection.Fig. 4. Immunotherapy strategies. Snapshots of granuloma state at different days
after the initiation of different immunotherapy strategies. The initial conditions
are for a typical containment scenario at day 150 post-infection. The first column
represent enhanced CD4 priming strategy, the second column enhanced CD4 and
CD8 priming and the last column enhanced APC trafficking. It takes approximately
10–15 days to resolve the inflammation after bacteria is cleared.Increasing APC trafficking can rescue the system and clear infection:
bacteria are gradually cleared and subsequently the granuloma
slowly dissolves (Fig. 4, enhanced APC trafficking column).
A similar outcome can be achieved by enhancing only CD4þ
T cell priming (Fig. 4, enhanced CD4 priming column).In contrast,
increasing CD8þ T cell priming does not affect granuloma
stability and can impair the beneficial effect of enhancing CD4þ
T cell priming: when combined, both effects do not achieve
clearance (Fig. 4, enhanced CD4/CD8 priming column). This likely
follows since once a macrophage is activated (CD4þ T cell
dependent), its intracellular bacterial load is completely cleared.
CTL killing releases some bacteria in the extracellular domain: in
a very densely packed environment such as an already formed
granuloma, bacteria released into the extracellular domain are
most likely internalized by other resting macrophages rather than
killed. This process will prevent immediate bacterial killing and
sustain the infection and the granuloma.4. Discussion
CD4þ and CD8þ T cell priming in a LN is a key step to
mounting a protective immune response to most bacterial infec-
tion, and Mtb is no exception. For TB, how events occurring in LNs
can impact granuloma formation and maintenance is still an open
question. Only a multi-organ model that takes into account
trafficking events can be used to capture the complexity of TB
and be useful for testing therapeutic and preventive strategies to
combat this disease. This study takes a multi-organ approach to
study TB granuloma formation, building onto an existing agent-
based model of the lung some of the main mechanisms of T cell
priming occurring in the lung-draining LN. The cellular dynamics
of the lymph node model are described with a sufficient level of
detail by a temporal-only representation (i.e., ODE system),
while the lung compartment requires spatial details to capture
the emergence of a unique spatial structure, a granuloma. We
recapitulate typical infection outcomes and predict both cell and
bacterial numbers in containment and dissemination scenarios,
based on the granuloma diameter (presently not measurable
experimentally).
Here we show that enhanced APC trafficking can drive the
system to clearance, both before or after a granuloma has been
established, suggesting a potential mechanism for successful
vaccination and immunotherapy strategies. We also show how
impaired APC migration can result in dissemination and uncon-
trolled growth of the bacteria. Unfortunately, the molecular and
cellular mechanisms governing pulmonary DC trafficking to the
lymph node are poorly understood. Most data are derived from
studying the migration of skin DCs, and it remains to be
determined whether these findings are applicable to DCs in other
tissues (Randolph et al., 2005). Assays that directly analyze DCs
transiting through lymphatic vessels are not available yet
(Randolph et al., 2005) and whether the regulation of this
trafficking controls the nature of adaptive immune responses in
the lung and in the granulomatous tissue is still an open question
(Cook and Bottomly, 2007).
Overall, we find that the role of effector T cells remains
essential for a successful initial immune response to Mtb inva-
sion: even if few effector T cells are present at the site, the IFNg
and TNF produced guarantee the necessary macrophage activa-
tion and containment is achieved ad well as a stable granuloma.
Manipulating the efficiency of T-cell–APC contacts in vivo rather
than the number of APC migrating to the LN can also be a viable
strategy to clear an infection, before a granuloma is fully
developed. This can be accomplished by increasing the duration
of the interaction (Celli et al., 2005, 2007), the cognate frequency
S. Marino et al. / Journal of Theoretical Biology 280 (2011) 50–62 61of naı¨ve T cells (Linderman et al., 2010; Zheng et al., 2008)
or having DC into the system that are highly immunogenic
(Steinman, 2001).
Another finding of our spatial multi-organ model is how
enhancing only effector CD4þ T cell differentiation can represent
a viable immunotherapy strategy for latently infected individuals,
where an infection can be cleared once a granuloma is fully
formed. CTL activity is a key to controlling the onset of infection
and possibly for clearance, but not when a granuloma has already
been established.
The computational modeling platform described herein can be
improved. First and obviously, more mechanisms and cells can be
included. For example anti-inflammatory cytokines (such as
IL-10) will be modeled explicitly (work in progress), as well as
including alternatively activated (AAM) and classically activated
(CAM) macrophages that we have explored previously (Marino
et al., 2010b) Two key improvements will be in modeling
explicitly dendritic cells and model bacterial dynamics in more
detail. We do not model bacteria metabolic states and we plan to
address replicating/slow replicating/dormant Mtb states in future
work. This will also give us the opportunity to capture mechan-
isms of tissue liquefaction (extracellular bacilli do not grow
unless there is liquefaction, see Grosset (2003)) and test the
dynamic hypothesis, suggested in recent work (Cardona, 2009). In
mice, the necrotic center of a granuloma comprises a ring of
foamy macrophages (Russell et al., 2009): we have not modeled
the kinetics of foamy macrophages from the granuloma to the
alveolar space, some of them carrying non-replicating bacilli, as
observed by different groups (Caceres et al., 2009; Cardona et al.,
2003; Ordway et al., 2006; Skold and Behar, 2008).
It is important to emphasize the modularity and tunable
resolution (Marino et al., 2010a) of this computational platform.
By tunable resolution we mean that we have the ability to fine-
grain or coarse-grain model components at will. We can achieve
containment ‘‘turning off’’ the LN-ODE component by using a
completely stochastic recruitment function, as shown in Fig. 2.
‘‘Turning on’’ the LN-ODE component with its more mechanistic
features allows us to gain insights into the trade-off between
number and quality of APCs migrating from the lung to the
priming compartment. We have previously predicted the non-
linear properties of these trade-offs within a virtual lymph node
environment (Linderman et al., 2010). Here, these key mechan-
isms are explicitly modeled in a computational representation of
granuloma formation and they can be manipulated to ultimately
control infection outcome.
A likely improvement will be to refine the granuloma envir-
onment in 3D. The limiting factor of a 3D implementation
revolves around how efficiently we model chemokine and cyto-
kine diffusion in a 3D environment. A single run of 200 days on a
current generation workstation takes approximately 1 h to com-
plete, with approximately 90–95% of the CPU time spent on
calculating diffusion. In 3D this results in an increase of the total
CPU time by a factor of 300–500 which poses issues of computa-
tional cost and time, especially if a comprehensive uncertainty
and sensitivity analysis is going to be performed (which means
hundreds of simulations).
We recently published a review (Marino et al., 2010a) emphasiz-
ing the importance of multi-scale, multi-organ modeling platforms
to capture the complexity of host–pathogen interactions in TB as
well as in any bacterial/viral infections. The work herein shows the
potentials of this approach, with a multi-organ (compartment)
agent-based model implementation. By incorporating events occur-
ring in both the lung and the draining LN, we gain insights into
immune mechanisms operating in different compartments that
regulate granuloma formation and maintenance. Ultimately, our
suggestions for viable vaccination and immunotherapy strategiescan be tested experimentally to aid in the prevention of spread of
infection and for treatment of latent TB.Acknowledgments
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